현대화학공업

비상장계속사업자

HYUNDAI CHEMICAL IND

이상녕

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

현대화학공업

Business Reg. No. 1358100964 · CEO 이상녕

I.Investment Overview

Target현대화학공업 (1358100964)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명현대화학공업
영문명HYUNDAI CHEMICAL IND
대표자이상녕
사업자등록번호1358100964
법인등록번호1345110007086
설립일1989.02.07
종업원수15명

V.Workforce

15

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW188.52021200.62022183.32023124.4202496.12025
영업이익100M KRW120215.52022-5.42023-52024-4.92025
순이익100M KRW-3.420212.52022-2.72023-5.220242.62025
Item20252024202320222021
자산총계147.4억원155.7억원158.9억원177.6억원168.3억원
부채총계42.3억원53.3억원51.2억원67.2억원60.4억원
자본총계105.1억원102.4억원107.7억원110.4억원107.8억원
매출액96.1억원124.4억원183.3억원200.6억원188.5억원
영업이익-4.9억원-5억원-5.4억원5.5억원9,813만원
순이익2.6억원-5.2억원-2.7억원2.5억원-3.4억원

VII.Financial Ratios

FY2025 basis

-5.12%

영업이익률

2.74%

순이익률

1.78%

ROA

2.5%

ROE

40.3%

부채비율

71.28%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

현대화학공업 투심보고서 | Alpha Lenz